RxDoctor Payments Data

Antonio Otero Lopez, MD

Adult Reconstructive Orthopaedic Surgery · Rio Piedras, PRNPI 1891802450

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $17,390 of the $21,172 with a category attached, or 82.1%. Stryker accounts for 88.9% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $18,198 and has fallen 96.7% since, to $600 in 2025.

$21,172in general payments, 2019–2025

Across 61 payments — averaging $347.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$19K
  • Smith+Nephew$652
  • Encore Medical, LP$579
  • Johnson And Johnson International$420
  • Zimmer Biomet$409
  • Amgen$125
  • plus $165 from 2 others

What the payments were for

  • Consulting fees$17,39082%
  • Travel & lodging$2331%
  • Food & beverage$3,54917%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker28$18,821
Smith+Nephew12$652
Encore Medical, LP2$579
Johnson And Johnson International9$420
Zimmer Biomet7$409
Amgen1$125
Medartis Inc.1$105
Johnson & Johnson1$60

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few adult reconstructive orthopaedic surgery providers in Puerto Ricoto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$12,788
Medicare patients
32
Services billed
60

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cefadroxil89$1,245
Diclofenac Potassium31$1,080
Nabumetone42$646
Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen39$585
Triamcinolone Acetonide26$238
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim15$125
Tramadol Hcl29$110

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Rio Piedras

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →